Position in INVA
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$2,097,000
+$597,750 QoQ
Shares Held
90,000
+20.0% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Janney Montgomery Scott LLC holds $101,269,363 across 48 Biotechnology names. INVA ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
84,324 | $37,654,038 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
|
2,016,464 | $16,192,205 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,078 | $10,104,585 | |
| 4 | INCY |
Incyte Corp
|
55,431 | $5,217,165 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,339 | $3,089,994 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
236,834 | $2,207,292 | |
| 7 | INVA |
Innoviva, Inc.
This page
|
90,000 | $2,097,000 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
12,030 | $2,033,310 |
All Filings in INVA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,097,000 | 90,000 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,499,250 | 75,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,825,000 | 100,000 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||